ClinicalTrials.Veeva

Menu

Stratifying Critically Ill Patients for Novel Ferroptosis or Pyroptosis Intervention Strategies (ICU-FERRO)

A

Antwerp University Hospital (UZA)

Status

Enrolling

Conditions

Trauma Related Injuries
Subarachnoid Haemorrhage (SAH)
Sepsis

Treatments

Diagnostic Test: Blood sampling

Study type

Interventional

Funder types

Other

Identifiers

NCT06928649
EDGE 3060

Details and patient eligibility

About

In order to better determine which therapy is best for patiënts which present with organ falure during the course of their stay in the intesive care unit (ICU) , one has to determine which underlying mechanism is causing this organ falure. We will determine levels of so called "biomarkers" for ferroptosis (a mechan ism of iron-related cell death) in the peripheral blood and biological fluids of criticaly ill patients admitted to the ICU with a catastrrophy (severe infection, trauma ...) . Why ? If it turns out that this ferroptosis plays a role in the ocurrence of organ failure in the critially ill, this will lead to new therapies in the future as drugs become more and more available which can influene this biochemical "pahway". of iron-relatd death.

Enrollment

600 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Admitted to the ICU of UZA
  • Critically ill and predicted to be hospitalised in the ICU for > 48 hours (i.e. mostly patients admitted for sepsis, trauma, haemorrhagic shock, neurological catastrophe ... which means at risk to develop mono-or multiple organ failure)
  • With arterial line in place (for blood sampling)

Exclusion criteria

  • Refusal of consent by patient or closest relative
  • Postoperative patients after major surgery in whom prolonged ICU stay is not foreseen (i.e. elective cardiac surgery

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

600 participants in 1 patient group

Critical illness
Experimental group
Description:
Patient who are admitted to the ICU, with a predicted length of stay \> 48 hours. Admission due to sepsis, trauma, haemorrhagic shock, neurological catastrophe
Treatment:
Diagnostic Test: Blood sampling

Trial contacts and locations

1

Loading...

Central trial contact

Tom Stroobants, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems